A lot of focus on today’s excellent update but can I draw everyone’s attention to this share on DXB’s LinkedIn page?
DXB was able to present to the largest renal conference in the world, in the USA one of the biggest slices of the market pie for us.
Booth co-hosted with Advanz Pharma, who we entered into a licence agreement for Europe, Canada, Australia & NZ.
https://www.advanzpharma.com/news/2023/advanz-pharma-and-dimerix-enter-into-an-exclusive-license-agreement-to-commercialise-dmx-200-in-europe-canada-australia-and-new-zealand
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
52.5¢ |
Change
-0.035(6.25%) |
Mkt cap ! $308.6M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 57.0¢ | 52.0¢ | $1.033M | 1.931M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 18732 | 52.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.5¢ | 30517 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| DXB (ASX) Chart |